Received: 11 June 2022
Accepted: 28 September 2022
First Online: 20 October 2022
: This study followed the Helsinki declaration. All participants signed an informed consent form and this study was approved by the Institutional Review Board of each hospital (Guigang People's Hospital, Bethune First Hospital of Jilin University, Fujian Cancer Hospital, West China Hospital of Sichuan University, Chongqing Third People's Hospital, Foshan First People's Hospital, Zhejiang Cancer Hospital, Yunnan Cancer Hospital, The First Affiliated Hospital of Sun Yat-sen University, Anhui Cancer Hospital, Chongqing Cancer Hospital, Chinese Academy of Medical Sciences Cancer Hospital, The First Affiliated Hospital of Kunming Medical University, Chongqing Daping Hospital, Tianjin Medical University Cancer Hospital, Wuhan Tongji Hospital, Xingtai People's Hospital) (Registration number: ChiCTR1800020329).
: Not applicable.
: The authors declare that they have no competing interests.